A company with a worldwide presence and a people-oriented approach to business needs a leader with a similar point of view. UCB Pharma could not have found a better fit than Anthony Tebbutt, with his eclectic background and diverse corporate experience, as well as his outlook on business and life.
As president of UCB Pharma Inc., the North American pharmaceutical subsidiary of Belgium-based UCB S.A., Mr. Tebbutt oversees a company that is old and new, national and international, as well as business and community minded. With headquarters in Brussels, UCB has total sales of about $2.5 billion and employs more than 10,000 people worldwide in 100 countries. The dominant part of UCB’s business is pharmaceuticals, though the company also has a substantial chemicals business and a film-wrapping business.
Though UCB Pharma has only had a presence in the United States for about eight years, the parent company this year celebrates its 75th anniversary. “Many people in the U.S. don’t realize that UCB has…
The R&D Equation